Table 1.

Demographic characteristics of MetS patients in the two treatment groups ^a

	Control group (Fasting alone)	Carnitine group (Fasting + L-carnitine)	P-valueb
Number	15	15	1.00
Gender (Female/Male)	10/5	11/4	0.702
Age (year)	46.8 ± 10.9(27–65)	46.9 ± 9.14(37–60)	0.973
Body mass (kg)	74.2 ± 6.9(59–86)	75.1 ± 7.5(64.1-93)	0.721
BMI (kg/m2)	27.4 ± 2.0(25–32.6)	28.2 ± 1.8(26.1-32.4)	0.348
WC (cm)	90.4 ± 4.99(83–98)	94.1 ± 6.0(84–107)	0.229
Metabolic disease
Hypertension	4	5	0.702
Impaired glucose tolerance	3	5	0.426
Dyslipidemia	12	13	0.638

Abbreviation: BMI body mass index, WC waist circumference.

^aVariables are expressed as mean ± SD.

^b P-value was determined by unpaired test.